-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Impending central retinal vein occlusion associated with cilioretinal artery obstruction
Case report
(2385) Views (956) Full article downloads
Authors: Juliana Mantovani Bottós, Fabio Bom Aggio, Eduardo Dib, Michel Eid Farah
Published Date October 2008
Volume 2008:2(3) Pages 665 - 668
DOI: http://dx.doi.org/10.2147/OPTH.S2694
Juliana Mantovani Bottós, Fabio Bom Aggio, Eduardo Dib, Michel Eid Farah
Vision Institute, Department of Ophthalmology, Federal University of São Paulo, Brazil
Abstract: We report a case of a patient with an impending central retinal vein occlusion (CRVO) with cilioretinal artery obstruction, which may help to understand the nature of the retinal hemodynamic changes associated with CRVO which shows direct evidence of arterial vasospasm, suggesting an increased contractility of retinal arteries. The clinical course, with initial retinal whitening along a cilioretinal artery followed by signs of venous stasis, seems to confirm the pathogenesis hypothesis concerning a primary arterial affection due to arterial vasospasm.
Keywords: retinal vein occlusion, cilioretinal artery obstruction, arterial spasm, fluorescein angiography
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia
- Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%




